Patent ID: 9561259
Date: 2017-02-07
CPC Classifications: A61K,A61P,C07K

Claim:
1. A method of treating a condition in a mammal, the method comprising administering to the mammal in need of the treatment a compound selected from the group consisting of: [(R)-(3-morpholin-4-yl-propylthio)-Sar] [(R)-(3-ethylisopropylamino-propylthio)-Sar] [(R)-(3-(4-methyl-piperazin-1-yl)-propylthio)-Sar] and pharmaceutically acceptable salts thereof; wherein the condition is selected from the group consisting of dry eye, blepharitis, meibomian gland disease, allergic conjunctivitis, pterygium, ocular symptoms of graft versus host disease, ocular allergy, atopic keratoconjunctivitis, vernal keratoconjunctivitis, uveitis, anterior uveitis, Behcet's disease, Steven Johnson syndrome, ocular cicatricial pemphigoid, chronic ocular surface inflammation caused by viral infection, herpes simplex keratitis, ocular rosacea and pinguecula; thereby treating the condition in the mammal.